1. Field of the Invention
This invention relates generally to the field of therapeutic drug delivery, and in particular to the delivery of therapeutic liquids to the respiratory system.
A wide variety of procedures have been proposed to deliver a drug to a patient. Of particular interest to the present invention are drug delivery procedures where the drug is in liquid form and is delivered to the patient's lungs. Effective intrapulmonary drug delivery depends on a variety of factors, some of which can be controlled by the clinician or scientist and others that are uncontrollable. Uncontrollable factors include, among others, the airway geometry of the patient's respiratory tract and lung and other respiratory diseases. Of the controllable factors, two are of particular interest. The first is the droplet size and droplet size distribution. The second is the breathing pattern.
A major factor governing the effectiveness of drug deposition in the lungs is the size of the inspired particles. Depending on the particle size, total deposition in various regions of the lung may vary from 11% to 98%. See Heyder et al., Aerosol Sci., 1986, 17, 811–825, the disclosure of which is herein incorporated by reference. Therefore, proper selection of particle size provides a way to target liquid droplets to a desired lung region. It is particularly difficult, however, to generate a liquid spray in which all the droplets will have the same size or the same aerodynamic behavior such that drug deposition in the desirable lung region is predictable.
A parameter that may be used to define droplet size is the respirable fraction (RF). The respirable fraction (RF) is defined as the fraction of the mass of aerosol droplets falling between a particular size range, usually in the range from about 1 μm to 6 μm. See D. C. Cipolla, et al., Assessment of Aerosol Delivery Systems for Recombinant Human Deoxyribonuclease, S.T.P. Pharma Sciences 4(1) 50–62, 1994, the disclosure of which is herein incorporated by reference. As used hereinafter, the term respirable fraction (RF) will include the percentage of droplets having sizes falling in the range of from about 1 μm to 6 μm. Another parameter that may be used to evaluate nebulization performance is the efficiency (E). The efficiency (E) of a nebulizer is the amount of liquid which is actually aerosolized and leaves the nebulizer in aerosolized form as compared to the amount of liquid that is initially supplied to the nebulizer. See D. C. Cipolla, et al., Assessment of Aerosol Delivery Systems for Recombinant Human Deoxyribonuclease, S.T.P. Pharma Sciences 4(1) 50–62, 1994. Still another parameter that may be used to measure the performance of nebulizers is the delivery percentage (D) which is the respirable fraction (RF) multiplied by the efficiency (E). See D. C. Cipolla, et al., Assessment of Aerosol Delivery Systems for Recombinant Human Deoxyribonuclease, S.T.P. Pharma Sciences 4(1) 50–62, 1994.
A variety of inhalation devices have been proposed including air jet nebulizers, ultrasonic nebulizers, and metered dose inhalers (MDIs). Air jet nebulizers usually utilize a high pressure air compressor and a baffle system that separates the small particles from the spray. Ultrasonic nebulizers generate ultrasonic waves with an oscillating piezoelectric crystal to produce liquid droplets. Another type of ultrasonic nebulizer of interest is described in U.S. Pat. Nos. 5,261,601 and 4,533,082. This nebulizer includes a housing that defines a chamber for holding a quantity of liquid to be dispensed. A perforated membrane is held over the chamber and defines a front wall of the chamber, with the rear surface of the membrane being in constant contact with the reservoir of liquid held in the chamber. The apparatus further includes an ultrasonic vibrator connected to the housing to vibrate the perforated membrane. Typical MDIs usually employ a gas propellant, such as CFC, which carries the therapeutic substance and is sprayed into the mouth of the patient.
Most commercially available inhalers produce sprays having a respirable fraction (RF) of 80% or less, with ultrasonic nebulizers usually having a respirable fraction (RF) of less than about 50%, thereby making dosing control difficult and inaccurate. Presently, most commercially available inhalers also have a poor efficiency (E), usually less than about 60%. See D. C. Cipolla, et al., Assessment of Aerosol Delivery Systems for Recombinant Human Deoxyribonuclease, S.T.P. Pharma Sciences 4(1) 50–62, 1994. Such inefficiency often results from the construction of the nebulizer since a certain amount cannot be nebulized and remains within the device. Since most commercially available nebulizers have both a poor respirable fraction (RF) and a poor efficiency (E), the delivery percentage (D) is also poor. Therefore, such inhalers have generally not been used for delivery of drugs that have potent therapeutic agents such as hormones and peptides or other drugs having a high level of toxicity and which can be expensive.
The second factor influencing droplet deposition is the patient's breathing pattern. Inhalation flow rate affects the probability of particle impact, while tidal volume and lung volume affect particle residence time in each lung region. Therefore, effective droplet deposition should be adaptable to the inhalation flow rate as well as the patient's tidal volume and lung volume.
Other important factors often considered when designing an effective therapeutic drug delivery system include both cost and convenience. When nebulizing the medicament, the apparatus involved usually comes in contact with the medicament. Hence, the apparatus will need to be sterilized before reuse, or discarded. However, sterilization may not be convenient for a hand held portable device. Disposal can also be expensive, particularly when the apparatus includes a piezoelectric crystal for nebulizing the liquid.
It would therefore be desirable to provide improved apparatus and methods for the delivery of liquids to the respiratory system. Such apparatus and methods should be capable of producing a spray which may predictably be deposited in selected regions of the lungs. Further, it would be desirable if such a spray were produced from a small volume of liquid. Moreover, it would be desirable if the apparatus and methods provided for a controlled drug delivery rate, preferably being based on the rate of inspiratory air flow generated during inhalation. Finally, it would be desirable if such methods and devices were inexpensive, efficient, and easy to use.
2. Brief Description of the Background Art
U.S. Pat. No. 4,533,082 describes a vibrating orifice apparatus with a multiplicity of apertures for producing liquid droplets.
As previously described, U.S. Pat. No. 5,261,601 describes an atomizer having a membrane covering a liquid chamber.
Apparatus for atomizing liquids such as liquid fuel, water, liquid drugs are described in U.S. Pat. Nos. 3,812,854; 4,159,803; 4,300,546; 4,334,531; 4,465,234; 4,632,311; 4,338,576; and 4,850,534.
D. C. Cipolla, et al., Assessment of Aerosol Delivery Systems for Recombinant Human Deoxyribonuclease, S.T.P. Pharma Sciences 4(1) 50–62, 1994, previously incorporated by reference, describes various inhalation devices and provides selected data on their efficiency (E) and respirable fraction (RF) values.
Anthony J. Hickey, Ed., Pharmaceutical Inhalation Aerosol Technology, Drugs and the Pharmaceutical Sciences, Vol. 54, pages 172–173, describes a container and a metering valve for an MDI. The container is specifically designed to hold a propellant to produce a spray.
The present invention provides methods and apparatus for the delivery of therapeutic liquids to the respiratory system of a patient. In one exemplary embodiment, the apparatus of the present invention is characterized in that it is able to produce a spray having a respirable fraction (RF) of greater than about 70%, preferably more than about 80%, and most preferably more than about 90%. Preferably, the apparatus will eject the liquid at a flow rate of at least about 5 μl/sec, and preferably more than about 10 μl/sec. By producing such a spray, the aerodynamic behavior of all the droplets will be substantially the same, thereby enabling the apparatus to be useful in intrapulmonary drug delivery.
The apparatus will preferably include a vibratable non-planar surface or non-planar member with apertures extending therethrough. The non-planar member will preferably comprise a rigid thin shell member having a front surface, a rear surface, and a plurality of apertures extending therebetween. The apertures are tapered so that they narrow from the rear surface to the front surface. A liquid supplier is provided which delivers liquid to the rear surface such that substantially all of the delivered liquid adheres to the thin shell member, and particularly within the large opening of the tapered apertures, by surface tension, i.e. in surface tension contact. A vibrator is further provided which vibrates the thin shell member to eject liquid droplets from the front surface of the thin shell member. Preferably, the apertures will be configured to eject liquid droplets having a respirable fraction (RF) of greater than about 70%, preferably more than about 80%, and most preferably more than about 90%. In another preferable aspect, the apparatus will have an efficiency (E) at or closely approaching 100%, i.e. substantially all liquid supplied to the rear surface will be aerosolized and will be available for inhalation. In this way, the delivery percentage (D) will usually be about the same as the respirable fraction (RF), i.e. greater than about 70%.
In one exemplary aspect, the size of the apertures at the front surface is in the range from about 1 μm to 6 μm, with the apertures have a slope at the front surface of about 10° or greater relative to a central axis of the apertures, preferably being in the range from about 10° to 20° relative to the central axis of the apertures, and more preferably being in the range from about 10° to 15° relative to the central axis. Preferably, the thin shell member will have a thickness of about 50 μm to about 100 μm, more preferably from about 75 μm to about 100 μm which provides the thin shell member with sufficient rigidity to vibrate in unison and provides sufficient aperture volume. In the present invention, ejection of droplets is developed due to the solid/fluid interaction inside the aperture, i.e. the interaction of the liquid against the tapered wall of the aperture. The cross sectional geometry of the aperture is therefore important. For example, if the aperture has a straight cylindrical wall with a slope of 0° relative to the central axis (or a 90° slope relative to the front surface of the thin shell member), ejection will not occur. Instead, the vibratory motion will cause the liquid to break loose from the vibratory surface so that it will not eject through the aperture.
For apertures smaller than 6 μm, the slope near the exit opening of the aperture is particularly important because the discharge coefficient of such an aperture is substantially smaller than for larger apertures. For apertures smaller than 6 μm, a slight variation in the slope near the small opening of the aperture will make significant influence on ejection of droplets because the tapered shape near the opening increases the surface area that is subjected to solid/fluid interaction near the exit opening. For example, vibration of the thin shell member when the apertures have a slope of 20° (relative to the central axis of the apertures) near the small opening produces 10 times more droplets than when the apertures are at right angles to the front surface. In this manner, a high flow rate can be achieved using a small thin shell member. A small thin shell member is desirable in that it has higher structural rigidity which assists in producing a fine spray as described hereinafter.
In another exemplary aspect, the thin shell member is hemispherical, parabolic, arc shaped, or curved in geometry, with the large opening of each aperture being located at the concave side, and the small opening of each aperture being located at the convex side. The thin shell member is preferably formed to have a low mass and a very high stiffens which causes the thin shell member to oscillate as a rigid body, i.e. homogeneously. In this way, all the apertures in the thin shell member are subject to the same amplitude so that droplets may be produced with a uniform size and with a desired respiratory fraction.
In one particular embodiment, the invention provides an apparatus for nebulizing a liquid having a housing with a proximal end and a distal end. A non-planar member, and preferably a thin shell member, is mounted within the housing, with thin shell member having a plurality of apertures for nebulizing the liquid upon vibration of the thin shell member. A vibrator is provided and is removably attached about the housing which vibrates the thin shell member. Preferably, the thin shell member is mounted within a dynamically isolated portion of the housing. In this manner, the vibration is not transmitted to the housing allowing the vibrator to be dismantled and reinstalled over the housing as desired.
Advantageously, the elements that come in contact with the mouth of the patient or with of the therapeutic liquid are held within the housing. Prior to use, the housing is connected to the vibrator which transmits vibratory motion to the thin shell member inside the housing to produce ejection of droplets which are then entrained in the inspiratory air flow. In this manner, the vibrator will not come into contact with the liquid, thereby allowing the vibrator to be reused with a new and uncontaminated housing. Such a configuration provides an economical nebulizing apparatus since the relatively expensive vibrator may be reused.
In a further exemplary embodiment of the present invention, an apparatus is provided which ejects a liquid spray at a rate synchronized with the inspiratory flow created during inhalation so the that ejection rate is proportional to the inspiratory flow rate. The apparatus includes a housing having a distal end and a mouthpiece at a proximal end. A non-planar member, and preferably a thin shell member, is mounted within the housing, with the thin shell member having a plurality of apertures. A vibrator is provided to vibrate the thin shell member and to eject liquid from the apertures. An acoustic chamber is provided within the housing which produces an audible signal during inhalation from the mouthpiece. Further provided is a controller for controlling the rate of thin shell member vibration upon detection of the audible signal. Preferably, the controller includes a microphone which detects the audible signal so that an electrical signal may be sent to the vibrator.
In this manner, the patient may simply breath through the mouthpiece (or a nasal adapter) to control the rate of droplet production. The respiratory flow passes through the acoustic chamber which produces the acoustic tone which is proportional to the inspiratory flow rate. Thus, the frequency of the acoustic tone indicates the inspiratory flow rate at any instant of the breathing cycle. Integration of the flow rate with time produces the tidal volume. Both the flow rate and the tidal volume can then be used to determine when the ejector should eject droplets and at what mass flow rate such that maximum deposition of droplets is obtained. Further, the acoustic tone may be recorded to produce a record of the breathing pattern of the patient which may be stored in a microprocessor. This information can be later used to synchronize the ejection of droplets for the same patient. Such information may also be later employed for other diagnostic purposes.
The invention further provides a method for nebulizing a liquid. According to the method, a non-planar member, preferably a thin shell member, having a plurality of tapered apertures extending therethrough is vibrated. The apertures in the thin shell member are configured to produce liquid droplets having a respirable fraction (RF) of greater than about 70%, preferably more than about 80%, and most preferably more than about 90%. In a preferable aspect, liquid is supplied to the thin shell member such that substantially all of the delivered liquid adheres to the thin shell member by surface tension. In this manner, the need for a container or a chamber to hold the liquid against the thin shell member is eliminated. Instead, the liquid is open to the atmosphere and is not subjected to pressurization or reflecting acoustic waves that may be produced within an adjacent chamber. Preferably, liquid will be supplied to the thin shell member by squeezing a liquid reservoir which dispenses a discrete volume of liquid onto the thin shell member. Usually, substantially all liquid delivered to the thin shell member will be transformed into liquid droplets that are available for inhalation, i.e. the efficiency (E) will be at or near 100%. In this way, the delivery percentage (D) will be substantially the same as the respirable fraction (RF).
In another aspect, the method provides for producing the liquid droplets at a rate greater than about 5 μliters per second. In another aspect, the vibrating step further comprises vibrating substantially all of the apertures in the thin shell member in unison. Preferably, the thin shell member will be vibrated at a frequency in the range from about 45 kHz to 200 kHz. In yet another aspect, the thin shell member is held within a housing having a mouthpiece, and the thin shell member is vibrated at a rate corresponding to an inspiratory flow rate through the mouthpiece. In one preferable aspect, the thin shell member is vibrated only during inhalation from the mouthpiece. Control of shell member vibration in this manner may be accomplished by producing an audible signal during inhalation and detecting the produced signal.
In one particular aspect, the vibrating step comprises removably attaching a vibrating source about a housing enclosing the thin shell member and actuating the vibrating source. Optionally, the vibrating source may be removed from the housing and the housing discarded after use.
The invention provides a further exemplary method for delivering a liquid to the lungs of a patient. According to the method, a housing is provided having a proximal end and a distal end. Liquid is supplied to an thin shell member disposed within the housing, with the thin shell member having a plurality of tapered apertures extending therethrough. The patient then inhales from the proximal end of the housing at a selected inspiratory flow rate, and the thin shell member is vibrated to eject the liquid at a rate corresponding to the inspiratory flow rate.
In one aspect of the method, the inspiratory flow rate is variable. In another aspect, the vibrating step further comprises ejecting the liquid only during inhalation. In still a further aspect, an audible signal is produced during inhalation and the produced signal is detected to control the rate of vibration of the thin shell member.
The thin shell member will preferably be vibrated to produce liquid droplets having a respirable fraction (RF) of greater than about 70%, preferably more than about 80%, and most preferably more than about 90%. In another preferable aspect, liquid will be supplied to the thin shell member such that substantially all of the delivered liquid adheres to the thin shell member by surface tension. Preferably, substantially all of the apertures in the thin shell member will be vibrated in unison.
The invention further provides an exemplary apparatus for nebulizing a liquid. The apparatus is particularly useful in accurately dispensing discrete quantities of a liquid, such as a single unit dosage of a liquid medicament. The apparatus comprises a thin shell member comprising a front surface, a rear surface, and a plurality of apertures extending therebetween. The apertures are tapered to narrow from the rear surface to the front surface. A liquid supplier is provided to deliver a predetermined unit volume of liquid to the rear surface. A vibrator vibrates the thin shell member to eject liquid droplets from the front surface of the thin shell member. Hence, by delivering only a unit volume of liquid to the rear surface and ejecting the entire unit volume, an apparatus for precisely nebulizing a known unit volume of liquid is provided.
In one exemplary aspect, the liquid supplier comprises a canister which holds the liquid under pressure. Usually, the canister will comprise a storage reservoir and a valve which allows the predetermined unit volume of liquid to be delivered from the canister when the valve is in an open position. In a preferable aspect, the valve comprises a chamber having a piston therein and a stem having a proximal end and a distal end. The stem includes an elongate groove at the distal end which places the storage reservoir and the chamber in fluid communication when the valve is in a closed position so that the chamber may be filled with liquid from the storage reservoir. The stem further includes a lumen at the proximal end which is placed in fluid communication with the chamber when the valve is in the open position such that a unit volume of the liquid within the chamber is forced out of the lumen and onto the rear surface of the thin shell member upon translation of the piston.
In another particular aspect, a spring is included adjacent the piston so that the piston may be automatically translated to force the unit volume of liquid from the chamber when the valve is in the open position. The pressure within the storage reservoir then compresses the spring to allow the chamber to be refilled with liquid from the storage reservoir when the valve is in the closed position.
In still another aspect, an acoustical sensor is provided which detects when the unit volume of liquid has been ejected from the thin shell member. Preferably, the acoustical sensor comprises a piezoelectric element. In this manner, a user may be informed as to whether all of the liquid supplied to the thin shell member has been nebulized. In yet another aspect, the apparatus includes a mouthpiece and a means for actuating the vibrator when a patient begins to inhale from the mouthpiece.
The invention also provides an exemplary method for nebulizing a single unit volume of liquid, such as a unit dosage of a liquid medicament. According to the method, a thin shell member is provided which comprises a front surface, a rear surface, and a plurality of apertures extending therebetween. The apertures are tapered to narrow from the rear surface to the front surface. A valve is then opened to deliver a unit volume of the liquid from a container and to the rear surface of the thin shell member. The thin shell member is vibrated until substantially all of the unit volume of the liquid on the rear surface is ejected from the front surface.
In one particular aspect, a piston is translated within the container sufficient to expel the unit volume of the liquid from the container and onto the rear surface when the valve is opened. Preferably, the valve is spring biased so that the piston will automatically translate upon opening of the valve. In another aspect, the container holds the liquid under pressure so that the piston will be translated in an opposite direction by force of the liquid to compress the spring when the valve is closed. In this way, the container will be refilled when the valve is closed.
In one exemplary embodiment, the container comprises a canister which holds the liquid in a pressurized storage reservoir. The valve comprises a chamber having a spring loaded piston therein and a stem having a proximal end and a distal end and an elongate groove at the distal end which places the storage reservoir and the chamber in fluid communication when the valve is in a closed position. In this manner, opening of the valve is accomplished by depressing the valve stem to place a lumen at the proximal end of the stem in fluid communication with the chamber so that a unit volume of the liquid within the chamber will be forced out the lumen upon translation of the piston.
In another particular aspect, a step is provided for sensing when the unit volume of liquid has been ejected from the thin shell member. Preferably, such sensing is accomplished by detecting a change of an acoustical signal generated by the vibrating thin shell member to indicate when the unit volume has been ejected. Preferably, the acoustical signal is sensed with a piezoelectric element.
In yet another aspect, a mouthpiece is provided which is spaced-apart from, the thin shell member. With such a configuration, a step is provided for sensing when a patient inhales from the mouthpiece and vibrating the thin shell member only during inhalation. In still another aspect, the unit volume of liquid that is nebulized is in the range from about 20 μl to about 100 μl.
The invention still further provides another exemplary apparatus for nebulizing a liquid. The apparatus comprises a thin shell member comprising a front surface, a rear surface, and a plurality of apertures extending therebetween, with apertures being tapered to narrow from the rear surface to the front surface. A liquid reservoir is provided, and a capillary system is in fluid communication with the liquid reservoir. The capillary system is disposed to draw liquid from the reservoir by capillary action for delivery to the rear surface of the thin shell member. A vibrator is also provided and vibrates the thin shell member to eject liquid droplets from the front surface of the thin shell member.
In one preferable aspect, the capillary system comprises a wicking member having a bottom end within the liquid reservoir and a delivery end hear the rear surface of the thin shell member. An outer member is spaced-apart from the wicking member by a capillary gap so that liquid from the reservoir may be drawn through the capillary gap and toward the delivery end by capillary action. Preferably, the wicking member further includes at least one capillary channel at the delivery end so that liquid delivered from the capillary gap may continue its travel to the rear surface of the thin shell member through the capillary channel. In another preferable aspect, a bottom portion of the wicking member is cylindrical in geometry, and the outer member includes an annular body which surrounds the wicking member.
In one exemplary aspect, the apparatus further includes a housing having a chamber and a mouthpiece, with the outer member being attached to the housing. The wicking member is attached to the liquid reservoir which in turn is detachably secured to the housing so that the liquid reservoir may be separated from the housing. In another aspect, the wicking member includes a flexible portion so that it may axially flex upon contact with the vibrating member. In this way, contact of the wicking member will not interfere with the performance of the vibratable member.
In still yet another aspect, the liquid reservoir has a concave shape and includes capillary channels which move the liquid toward the capillary gap between the outer member and the wicking member. A power supply is further provided which supplies power to the vibrator. The power supply may comprise a battery, a rechargeable battery, an AC or a DC power source, or the like.
The invention still further provides an exemplary method for nebulizing a liquid by providing a thin shell member comprising a front surface, a rear surface, and a plurality of apertures extending therebetween. The apertures are tapered to narrow from the rear surface to the front surface. Liquid is drawn from a liquid reservoir by capillary action to place the liquid in contact with the rear surface of the thin shell member. The thin shell member is vibrated to eject the liquid on the rear surface from the front surface, with liquid being continuously supplied from the liquid reservoir to the rear surface as the thin shell member is vibrated. In this manner, substantially all of the liquid within the reservoir may be nebulized.
In one exemplary aspect, the capillary action is provided by a capillary gap between a wicking member and an outer member, with the wicking member having a bottom end within the liquid reservoir and a delivery end near the rear surface of the thin shell member. The capillary action may optionally be augmented by providing at least one capillary channel at the delivery end of the wicking member so that liquid from the capillary gap may continue its travel to the thin shell member.
In another aspect of the method, a housing is provided having a chamber, a mouthpiece, the outer member, and the vibratable member. In this manner, the reservoir may be attached to the housing prior to vibrating the vibratable member. After nebulizing the liquid, the housing may be detached from the reservoir so that the housing and reservoir may be washed. In another exemplary aspect, the housing may be titled while nebulizing the liquid, thereby allowing a patient to inhale from the mouthpiece while lying down. In still another aspect, at least some of the liquid is transferred from the liquid reservoir and to the capillary gap by capillary action.
The invention provides methods and apparatus for producing a very fine spray useful in pulmonary drug delivery procedures. The invention provides for producing a spray having a respirable fraction (RF) of greater than about 70%, preferably more than about 80%, and most preferably more than about 90%. The efficiency (E) of the nebulization apparatus will usually be at or near 100%, leading to a delivery percentage (D) which is substantially the same as the respirable fraction (RF). Such a spray will preferably be produced at a flow rate of at least about 5 μl per second, and more preferably at least about 10 μl per second. In this manner, a spray of a selected size is produced where the aerodynamic behavior of all the droplets is substantially the same, thereby enabling the spray to be predictably deposited in selected regions of the lungs during intrapulmonary drug delivery procedures.
The invention may be employed to deliver a wide variety of drugs to the respiratory system, and will preferably be used to deliver drugs having potent therapeutic agents, such as hormones, peptides, and other drugs requiring precise dosing. Liquid drugs which may be nebulized using the present invention include drugs in solution form (e.g., in aqueous solution, ethanol solution, aqueous/ethanol mixture solution, and the like), in colloidal suspension form, and the like.
The invention will preferably be configured to supply the spray upon demand, i.e., the spray will be produced and delivered only upon inhalation by the patient. Further, such a spray will preferably be produced and delivered at a rate corresponding to the inhalation or inspiratory flow rate produced by the patient when inhaling the spray. In this manner, the spray will be produced only when the patient is inhaling, and will preferably be produced at a rate corresponding to the inhalation rate.
The invention will provide such a spray by providing the liquid to a vibratable non-planar member, which is preferably a thin shell member having a plurality of apertures. Liquid is preferably supplied to the thin shell member such that substantially all of the delivered liquid will adhere to the thin shell member by surface tension. Upon vibration of the thin shell member, the adhering liquid will be ejected through the apertures to form the fine spray. In this manner, a precise and controlled amount of liquid drug can be supplied to the thin shell member for nebulization, thereby eliminating the need for a fluid reservoir to be placed against the thin shell member.
Apertures in the thin shell member of the invention will preferably be tapered in geometry, with the smaller end of the aperture being located at a front surface of the thin shell member and the larger opening of the aperture being at the rear surface of the thin shell member. The size of the apertures at the front surface will preferably be in the range from about 1 μm to 6 μm, with the slope of the apertures at the front surface being in the range from about 10° or greater relative to a central axis extending through the apertures, preferably from about 10° to 20° relative to the central axis extending through the apertures, and more preferably being in the range from about 10° to 15° relative to the central axis.
Referring now to the figures, an exemplary embodiment of a nebulizing apparatus 10 will be described. As best illustrated in
Referring to
An amount of liquid 42 is supplied to the rear surface 40 from the liquid supply cartridge 24. The liquid cartridge 24 includes a divider 44 that separates the liquid supply cartridge 24 into an air volume 46 and a liquid volume 48. To dispense liquid from the liquid volume 48, the liquid supply cartridge 24 is squeezed to force liquid in the liquid volume 48 through a nozzle 50 where it comes into contact with the rear surface 40 of the thin shell member 36. The cartridge 24 becomes permanently deformed when squeezed so that the liquid 42 delivered to the rear surface 40 will not be withdrawn back into the liquid volume 48. The size of the air volume 46 will be configured such that all of the liquid within the liquid volume 48 will be transferred from the liquid volume 48 when the cartridge 24 is squeezed.
The liquid 42 delivered from the supply cartridge 24 will usually be held to the rear surface 40 solely by surface tension forces. In this way, the liquid 42 may remain in contact with the rear surface 40 until ejected and without the need for a separate chamber to hold the liquid 42 against the rear surface 40. To eject the liquid 42 from the front surface 38, the carrier plate 26 is vibrated to in turn vibrate the thin shell member 36. The liquid 42 adhering to the rear surface then passes through the apertures and from the front surface 38 as described in U.S. Pat. No. 5,164,740 and copending application Ser. No. 08/163,850 filed Dec. 7, 1993 and Ser. No. 08/417,311, filed Apr. 5, 1995, the entire disclosures of which are herein incorporated by reference.
The thin shell member 36 is preferably formed of a thin, rigid material having a hemispherical geometry. Alternatively, the thin shell member 36 may be parabolic, arc shaped, or curved in geometry. The thin shell member 36 will have a very high bending stiffness which will allow it to follow the vibratory motion of the carrier plate 26 as a rigid body. In this way, the entire thin shell member 36 will vibrate in unison so that all apertures are subject to the same amplitude of vibration. Such vibration will assist in ejecting uniformly sized droplets (i.e. having a respirable fraction (RF) of greater than about 70%, preferably more than about 80%, and most preferably more than about 90%) simultaneously from most or all of the apertures. The spray produced by the thin shell member 36 is dispensed into the central chamber 32 in the direction of the opening 34. In this manner, as the patient inhales from the mouthpiece 22, the spray within the central chamber 32 will be drawn into the patient's lungs.
To control the time and/or rate at which the spray is produced, the mouthpiece assembly 12 further includes an acoustic chamber 52 having holes 54 and 56. Upon inhalation, air within the central chamber 32 passes through the holes 54 and 56 to produce an acoustic tone. This tone may be detected as described in greater detail hereinafter and used to determine both when the patient is inhaling and the patient's inspiratory flow rate. Such a signal may then be used to actuate the oscillating assembly which vibrates the thin shell member 36. Such a signal may be employed to control the time at which the shell member 36 is vibrated, e.g., such as only during inhalation. Alternatively, such a signal may also be employed to vibrate the thin shell member 36 at a frequency corresponding to the inspiratory flow rate.
Referring now to
The mouthpiece assembly 12 is connected to the oscillating assembly 14 by sliding the proximal end 18 of the mouthpiece assembly 12 through an opening 58 (see
The cantilever beam 60 is provided with a free end 62 and a fixed end 64. The fixed end 64 is attached to an electronic circuit board 66 by a pair of screws 65, thus limiting the ability of the fixed end 64 to vibrate. On the other hand, the free end 62 which is attached to the mouthpiece assembly 12 is free to vibrate. A piezoelectric element 68 is bonded to the beam 60 and transmits vibratory motion to the beam 60. The dimensions of the beam 60 may be varied depending on the frequency of vibration. In one particular embodiment which is usually vibrated at 45 kHz to 200 kHz, the beam 60 will preferably have a length of about 30 mm to 80 mm, preferably at about 40 mm, a width of about 8 mm to 15 mm, preferably at about 12 mm, and a thickness of about 0.5 mm to 1 mm, preferably at about 0.7 mm. Such a beam will preferably be oscillated at a frequency of about 45 kHz which corresponds to the natural frequency of the beam. When vibrated, the beam 60 will have an oscillation mode shape 70 as illustrated in phantom line in
Upon vibration of the cantilever beam 60, the elastomeric material of the housing 16 prevents transfer of vibratory energy through the tubular housing 16. In this manner, only the carrier plate 26 and the adjacent portion of the housing 16 are vibrated so that only minimal energy is needed to sufficiently vibrate the thin shell member 36. The cantilever beam 60 will preferably be vibrated to produce an oscillation amplitude of about 0.001 mm at the free end 62. Such vibration is transferred to the thin shell member 36 via the carrier plate 26 to produce a fine spray particles having a desired respirable fraction (RF).
In one experiment, the apparatus 10 of
To operate the nebulizing apparatus 10, the patient first attaches the mouthpiece assembly 12 to the oscillating assembly 14 as previously described. The liquid supply cartridge 24 is then squeezed to transfer the liquid to the rear surface 38 of the thin shell member 36. The patient then places his mouth over the mouthpiece 22 and begins to inhale. As air is drawn through the central chamber 32, an acoustic tone is produced by the acoustic chamber 52. As illustrated in
Referring to
Referring to
Referring to
System 100 is provided with a source of liquid 106 which is preferably held under pressure. Liquid from source 106 passes through a line 108, through a valve 110 (shown in an open configuration), through a line 112, and into a metering chamber 114. Metering chamber 14 includes a spring biased piston 116 which is moved against a stop 118 when chamber 14 is filled with the liquid. When piston 116 is against stop 118, metering chamber 114 contains a unit volume so that when piston 116 is fully translated as shown in FIG. 10, a unit volume of liquid will be expelled into a line 120. Connected to line 120 is a valve 122 which is in a closed configuration in
When metering chamber 114 is full, valve 110 is closed as shown in
Referring now to
As best shown in
Referring to
Vibratable member 164 is caused to vibrate by a piezoelectric element 166. Piezoelectric element 166 in turn is electrically connected to a printed circuit board 168 by wires 169, with the circuit board 168 having the electronics necessary to vibrate piezoelectric element 166. Vibratable member 164 may be constructed similar to and vibrated at frequencies similar to those previously described herein and in U.S. Pat. No. 5,164,740 and U.S. patent application Ser. Nos. 08/163,850, filed Dec. 7, 1993 and Ser. No. 08/417,311, filed Apr. 5, 1995, previously incorporated by reference. Power is supplied to circuit board 168 from batteries 140, which may optionally be rechargeable as previously described.
Vibratable member 164 is fixedly attached housing 130 by a pair of mounting screws 170 and 172. Vibratable member 164 is bent so that thin shell member 162 will be positioned to eject liquid into mouthpiece 134.
As a patient draws upon mouthpiece 134, air is drawn into housing 130 through a plurality of air inlets 174. In this manner, outside air sweeps through an acoustic chamber 176 so that the patient may inhale nebulized liquid produced from the thin shell member 162. Acoustic chamber 176 is used in combination with a microphone 178 on circuit board 168 to control actuation of piezoelectric element 166. Such an operation is similar to the embodiment of
Apparatus 128 further includes an acoustical sensor 161 to detect when the unit volume of liquid has been ejected from thin shell member 162. Sensor 161 preferably comprises a piezoelectric element which vibrates from an acoustical signal generated when liquid adheres to the rear surface of thin shell member 162. When all of the liquid is ejected, sensor 161 will cease to vibrate indicating that all of the liquid has been nebulized.
Referring now to
As previously described, valve 150 includes stem 152 which is secured to container 144 by an insert 180 and a cap 182. Positioned over stem 152 is a cylindrical seal 184, an O-ring seal 186, a piston 188, a metering chamber member 190, and a washer 192. Stem 152 further includes an elongate groove 194 at proximal end 154. A lumen 196 extends through stem 152 at distal end 156 and terminates in a side port 198.
Valve 150 is shown in a closed configuration in
Dispensing of a unit volume amount of liquid from valve 150 is illustrated in
After the unit volume of liquid has been dispensed from valve 150, first spring 200 will again translate stem 152 against washer 192 as shown in
Referring now to
Vibratable member 230 is connected to housing 208 via an adapter 234, which also functions as a connector for an external power supply. A mounting plate 236 is placed between adapter 234 and vibratable member 230. Vibratable member 230 and thin shell member 228 may be constructed essentially identical to embodiments previously described herein and will operate in a similar manner. A lid 238 (see
Referring to
Although the size of capillary channels 248 may vary depending upon the type of liquid to be nebulized, capillary channels 248 will preferably have a gap in the range from about 50 μm to about 250 μm, and more preferably from about 100 μm to about 200 μm.
Preferably, tip 244 will be in contact with thin shell member 228 during vibration to ensure that liquid at tip 244 will be delivered to thin shell member 228. To ensure that wicking member 226 will not interfere with the vibration of thin shell member 228, wicking member 226 includes a plurality of cutouts 252 which provide body 240 with axial flexibility. The cutouts 252 therefore allow for manufacturing tolerances to be eased when constructing the wicking member. Body 240 will preferably be constructed of an ABS plastic (which has good wetting capabilities) so that, with the assistance of cutouts 252, body 240 will axially flex as thin shell member 228 is vibrated. Wicking member 226 may optionally be spring-loaded to prevent vibrational interference with vibratable member 230.
Referring now to
Vibratable member 230 includes a piezoelectric element 260 which vibrates thin shell member 228 as previously described to eject liquid into chamber 210. Hence, by employing wicking member 226, substantially all of the liquid supplied to reservoir 218 will be drawn to tip 244 where it may be nebulized by thin shell member 228. In this manner, it can be assured that all the liquid will be nebulized.
Referring back to
As best shown in
Referring now to
Alternatively, a variety of other power sources may be employed to operate apparatus 206. For example, as illustrated in
Although the foregoing invention has been described in detail for purposes of clarity of understanding, it will be appreciated that certain changes and modifications may be practiced within the scope of the appended claims.
This application is a continuation of Ser. No. 10/222,178 Aug. 15, 2002 U.S. Pat. No. 6,640,804 Ser. No. 10/222,178 is a continuation of Ser. No. 09/574,168 May. 18, 2000 U.S. Pat No. 6,467,476 Ser. No. 09/574,168 is a continuation of Ser. No. 09/058,344 Apr. 10, 1998 U.S. Pat No. 6,085,740 Ser. No. 09/058,344 is a continuation of Ser. No. 08/604,313 Feb. 21, 1996 U.S. Pat No. 5,758,637 Ser. No. 08/604,313 is a continuation of Ser. No. 08/521,641 Aug. 31, 1995 U.S. Pat No. 5,586,550 Ser. No. 10/655,642 a CIP of Ser. No. 08/417,311 Apr. 5, 1995 U.S. Pat No. 5,938,117.
Number | Name | Date | Kind |
---|---|---|---|
550315 | Allen | Nov 1895 | A |
809159 | Willis et al. | Jan 1906 | A |
1680616 | Horst | Aug 1928 | A |
2022520 | Philbrick | Nov 1935 | A |
2101304 | Wright | Dec 1937 | A |
2158615 | Wright | May 1939 | A |
2187528 | Wing | Jan 1940 | A |
2223541 | Baker | Dec 1940 | A |
2266706 | Fox et al. | Dec 1941 | A |
2283333 | Martin | May 1942 | A |
2292381 | Klagges | Aug 1942 | A |
2360297 | Wing | Oct 1944 | A |
2375770 | Dahlberg | May 1945 | A |
2383098 | Wheaton | Aug 1945 | A |
2404063 | Healy | Jul 1946 | A |
2430023 | Longmaid | Nov 1947 | A |
2474996 | Wallis | Jul 1949 | A |
2512004 | Wing | Jun 1950 | A |
2521657 | Severy | Sep 1950 | A |
2681041 | Zodtner et al. | Jun 1954 | A |
2705007 | Gerber | Mar 1955 | A |
2735427 | Sullivan | Feb 1956 | A |
2764946 | Henderson | Oct 1956 | A |
2764979 | Henderson | Oct 1956 | A |
2779623 | Eisenkraft | Mar 1957 | A |
2935970 | Morse et al. | May 1960 | A |
3103310 | Lang | Sep 1963 | A |
3325031 | Singier | Jun 1967 | A |
3411854 | Rosler et al. | Nov 1968 | A |
3515348 | Coffman, Jr. | Jun 1970 | A |
3550864 | East | Dec 1970 | A |
3558052 | Dunn | Jan 1971 | A |
3561444 | Boucher | Feb 1971 | A |
3563415 | Ogle | Feb 1971 | A |
3680954 | Frank | Aug 1972 | A |
3719328 | Hindman | Mar 1973 | A |
3738574 | Guntersdorfer et al. | Jun 1973 | A |
3771982 | Dobo | Nov 1973 | A |
3790079 | Berglund et al. | Feb 1974 | A |
3804329 | Martner | Apr 1974 | A |
3812854 | Michaels et al. | May 1974 | A |
3838686 | Szekely | Oct 1974 | A |
3842833 | Ogle | Oct 1974 | A |
3865106 | Palush | Feb 1975 | A |
3903884 | Huston et al. | Sep 1975 | A |
3906950 | Cocozza | Sep 1975 | A |
3908654 | Lhoest et al. | Sep 1975 | A |
3950760 | Rauch et al. | Apr 1976 | A |
3951313 | Coniglione | Apr 1976 | A |
3958249 | DeMaine et al. | May 1976 | A |
3970250 | Drews | Jul 1976 | A |
3983740 | Danel | Oct 1976 | A |
3993223 | Welker, III et al. | Nov 1976 | A |
4005435 | Lundquist et al. | Jan 1977 | A |
4030492 | Simbruner | Jun 1977 | A |
4052986 | Scaife | Oct 1977 | A |
4059384 | Holland et al. | Nov 1977 | A |
D246574 | Meierhoefer | Dec 1977 | S |
4076021 | Thompson | Feb 1978 | A |
4083368 | Freezer | Apr 1978 | A |
4094317 | Wasnich | Jun 1978 | A |
4101041 | Mauro, Jr. et al. | Jul 1978 | A |
4106503 | Rosenthal et al. | Aug 1978 | A |
4109174 | Hodgson | Aug 1978 | A |
4113809 | Abair et al. | Sep 1978 | A |
D249958 | Meierhoefer | Oct 1978 | S |
4119096 | Drews | Oct 1978 | A |
4121583 | Chen | Oct 1978 | A |
4159803 | Cameto et al. | Jul 1979 | A |
4207990 | Weiler et al. | Jun 1980 | A |
4210155 | Grimes | Jul 1980 | A |
4226236 | Genese | Oct 1980 | A |
4240081 | Devitt | Dec 1980 | A |
4240417 | Holever | Dec 1980 | A |
4248227 | Thomas | Feb 1981 | A |
4261512 | Zierenberg | Apr 1981 | A |
D259213 | Pagels | May 1981 | S |
4268460 | Boiarski et al. | May 1981 | A |
4294407 | Reichl et al. | Oct 1981 | A |
4298045 | Weiler et al. | Nov 1981 | A |
4299784 | Hense | Nov 1981 | A |
4300546 | Kruber | Nov 1981 | A |
4301093 | Eck | Nov 1981 | A |
4319155 | Makai et al. | Mar 1982 | A |
4334531 | Reichl et al. | Jun 1982 | A |
4336544 | Donald et al. | Jun 1982 | A |
4338576 | Takahashi et al. | Jul 1982 | A |
4368476 | Uehara et al. | Jan 1983 | A |
4368850 | Szekely | Jan 1983 | A |
4374707 | Pollack | Feb 1983 | A |
4389071 | Johnson et al. | Jun 1983 | A |
4408719 | Last | Oct 1983 | A |
4428802 | Kanai et al. | Jan 1984 | A |
4431136 | Janner et al. | Feb 1984 | A |
4454877 | Miller et al. | Jun 1984 | A |
4465234 | Maehara et al. | Aug 1984 | A |
4474251 | Johnson, Jr. | Oct 1984 | A |
4474326 | Takahashi | Oct 1984 | A |
4475113 | Lee et al. | Oct 1984 | A |
4479609 | Maeda et al. | Oct 1984 | A |
4512341 | Lester | Apr 1985 | A |
4530464 | Yamamoto et al. | Jul 1985 | A |
4533082 | Maehara et al. | Aug 1985 | A |
4539575 | Nilsson | Sep 1985 | A |
4544933 | Heinzl | Oct 1985 | A |
4546361 | Brescia et al. | Oct 1985 | A |
4550325 | Viola | Oct 1985 | A |
4566452 | Farr | Jan 1986 | A |
4591883 | Isayama | May 1986 | A |
4593291 | Howkins | Jun 1986 | A |
4605167 | Maehara | Aug 1986 | A |
4613326 | Szwarc | Sep 1986 | A |
4620201 | Heinzl et al. | Oct 1986 | A |
4628890 | Freeman | Dec 1986 | A |
4632311 | Nakane et al. | Dec 1986 | A |
4658269 | Rezanka | Apr 1987 | A |
4659014 | Soth et al. | Apr 1987 | A |
4677975 | Edgar et al. | Jul 1987 | A |
4678680 | Abowitz | Jul 1987 | A |
4679551 | Anthony | Jul 1987 | A |
4681264 | Johnson, Jr. | Jul 1987 | A |
4693853 | Falb et al. | Sep 1987 | A |
4702418 | Carter et al. | Oct 1987 | A |
4722906 | Guire | Feb 1988 | A |
4753579 | Murphy | Jun 1988 | A |
4790479 | Matsumoto et al. | Dec 1988 | A |
4793339 | Matsumoto et al. | Dec 1988 | A |
4796807 | Bendig et al. | Jan 1989 | A |
4799622 | Ishikawa et al. | Jan 1989 | A |
4805609 | Roberts et al. | Feb 1989 | A |
4819629 | Jonson | Apr 1989 | A |
4819834 | Thiel | Apr 1989 | A |
4826080 | Ganser | May 1989 | A |
4826759 | Guire et al. | May 1989 | A |
4828886 | Hieber | May 1989 | A |
4843445 | Stemme | Jun 1989 | A |
4849303 | Graham et al. | Jul 1989 | A |
4850534 | Takahashi et al. | Jul 1989 | A |
4865006 | Nogi et al. | Sep 1989 | A |
4871489 | Ketcham | Oct 1989 | A |
4872553 | Suzuki et al. | Oct 1989 | A |
4877989 | Drews et al. | Oct 1989 | A |
4888516 | Daeges et al. | Dec 1989 | A |
4922901 | Brooks et al. | May 1990 | A |
4926915 | Deussen et al. | May 1990 | A |
4934358 | Nilsson et al. | Jun 1990 | A |
4954225 | Bakewell | Sep 1990 | A |
4957239 | Tempelman | Sep 1990 | A |
4964521 | Wieland et al. | Oct 1990 | A |
D312209 | Morrow et al. | Nov 1990 | S |
4968299 | Ahlstrand et al. | Nov 1990 | A |
4971665 | Sexton | Nov 1990 | A |
4973493 | Guire | Nov 1990 | A |
4976259 | Higson et al. | Dec 1990 | A |
4979959 | Guire | Dec 1990 | A |
4994043 | Ysebaert | Feb 1991 | A |
5002048 | Makiej, Jr. | Mar 1991 | A |
5002582 | Guire et al. | Mar 1991 | A |
5007419 | Weinstein et al. | Apr 1991 | A |
5016024 | Lam et al. | May 1991 | A |
5021701 | Takahashi et al. | Jun 1991 | A |
5022587 | Hochstein | Jun 1991 | A |
5024733 | Abys et al. | Jun 1991 | A |
5046627 | Hansen | Sep 1991 | A |
5062419 | Rider | Nov 1991 | A |
5063396 | Shiokawa et al. | Nov 1991 | A |
5063922 | Hakkinen | Nov 1991 | A |
5073484 | Swanson et al. | Dec 1991 | A |
5076266 | Babaev | Dec 1991 | A |
5080093 | Raabe et al. | Jan 1992 | A |
5080649 | Vetter | Jan 1992 | A |
5086765 | Levine | Feb 1992 | A |
5086785 | Gentile et al. | Feb 1992 | A |
5115803 | Sioutas | May 1992 | A |
5115971 | Greenspan et al. | May 1992 | A |
5117148 | Nakamura et al. | May 1992 | A |
D327008 | Friedman | Jun 1992 | S |
5122116 | Kriesel et al. | Jun 1992 | A |
5129579 | Conte | Jul 1992 | A |
5134993 | Van Der Linden et al. | Aug 1992 | A |
5139016 | Waser | Aug 1992 | A |
5140740 | Weigelt | Aug 1992 | A |
5147073 | Cater | Sep 1992 | A |
5152456 | Ross et al. | Oct 1992 | A |
5157372 | Langford | Oct 1992 | A |
5164740 | Ivri | Nov 1992 | A |
5169029 | Behar et al. | Dec 1992 | A |
5170782 | Kocinski | Dec 1992 | A |
5180482 | Abys et al. | Jan 1993 | A |
5186164 | Raghuprasad | Feb 1993 | A |
5186166 | Riggs et al. | Feb 1993 | A |
5198157 | Bechet | Mar 1993 | A |
5201322 | Henry et al. | Apr 1993 | A |
5213860 | Laing | May 1993 | A |
5217148 | Cater | Jun 1993 | A |
5217492 | Guire et al. | Jun 1993 | A |
5227168 | Chvapil | Jul 1993 | A |
5230496 | Shillington et al. | Jul 1993 | A |
5245995 | Sullivan et al. | Sep 1993 | A |
5248087 | Dressler | Sep 1993 | A |
5258041 | Guire et al. | Nov 1993 | A |
5261601 | Ross et al. | Nov 1993 | A |
5263992 | Guire | Nov 1993 | A |
5279568 | Cater | Jan 1994 | A |
5297734 | Toda | Mar 1994 | A |
5299739 | Takahashi et al. | Apr 1994 | A |
5303854 | Cater | Apr 1994 | A |
5309135 | Langford | May 1994 | A |
5312281 | Takahashi et al. | May 1994 | A |
5313955 | Rodder | May 1994 | A |
5319971 | Osswald et al. | Jun 1994 | A |
5320603 | Vetter et al. | Jun 1994 | A |
5322057 | Raabe et al. | Jun 1994 | A |
5342011 | Short | Aug 1994 | A |
5342504 | Hirano et al. | Aug 1994 | A |
5347998 | Hodson et al. | Sep 1994 | A |
5348189 | Cater | Sep 1994 | A |
5350116 | Cater | Sep 1994 | A |
5355872 | Riggs et al. | Oct 1994 | A |
5357946 | Kee et al. | Oct 1994 | A |
5372126 | Blau | Dec 1994 | A |
5383906 | Burchett et al. | Jan 1995 | A |
5388571 | Roberts et al. | Feb 1995 | A |
5392768 | Johansson et al. | Feb 1995 | A |
5396883 | Knupp et al. | Mar 1995 | A |
5414075 | Swan et al. | May 1995 | A |
5415161 | Ryder | May 1995 | A |
5419315 | Rubsamen | May 1995 | A |
5426458 | Wenzel et al. | Jun 1995 | A |
5431155 | Marelli | Jul 1995 | A |
5435282 | Haber et al. | Jul 1995 | A |
5435297 | Klein | Jul 1995 | A |
5437267 | Weinstein et al. | Aug 1995 | A |
5445141 | Kee et al. | Aug 1995 | A |
D362390 | Weiler | Sep 1995 | S |
5449502 | Igusa et al. | Sep 1995 | A |
5452711 | Gault | Sep 1995 | A |
5458135 | Patton et al. | Oct 1995 | A |
5458289 | Cater | Oct 1995 | A |
5474059 | Cooper | Dec 1995 | A |
5477992 | Jinks et al. | Dec 1995 | A |
5479920 | Piper et al. | Jan 1996 | A |
5487378 | Robertson et al. | Jan 1996 | A |
5489266 | Grimard | Feb 1996 | A |
5497944 | Weston et al. | Mar 1996 | A |
D369212 | Snell | Apr 1996 | S |
5511726 | Greenspan et al. | Apr 1996 | A |
5512329 | Guire et al. | Apr 1996 | A |
5512474 | Clapper et al. | Apr 1996 | A |
5515841 | Robertson et al. | May 1996 | A |
5515842 | Ramseyer et al. | May 1996 | A |
5516043 | Manna et al. | May 1996 | A |
5518179 | Humberstone et al. | May 1996 | A |
5529055 | Gueret | Jun 1996 | A |
5533497 | Ryder | Jul 1996 | A |
5542410 | Goodman et al. | Aug 1996 | A |
5549102 | Lintl et al. | Aug 1996 | A |
5560837 | Trueba | Oct 1996 | A |
5563056 | Swan et al. | Oct 1996 | A |
D375352 | Bologna | Nov 1996 | S |
5579757 | McMahon et al. | Dec 1996 | A |
5582330 | Iba | Dec 1996 | A |
5584285 | Salter et al. | Dec 1996 | A |
5586550 | Ivri et al. | Dec 1996 | A |
5588166 | Burnett | Dec 1996 | A |
5601077 | Imbert | Feb 1997 | A |
5609798 | Liu et al. | Mar 1997 | A |
5632878 | Kitano | May 1997 | A |
5635096 | Singer et al. | Jun 1997 | A |
5637460 | Swan et al. | Jun 1997 | A |
5647349 | Ohki et al. | Jul 1997 | A |
5653227 | Barnes et al. | Aug 1997 | A |
5654007 | Johnson et al. | Aug 1997 | A |
5654162 | Guire et al. | Aug 1997 | A |
5654460 | Rong | Aug 1997 | A |
5657926 | Toda | Aug 1997 | A |
5660166 | Lloyd | Aug 1997 | A |
5664557 | Makiej, Jr. | Sep 1997 | A |
5664706 | Cater | Sep 1997 | A |
5665068 | Takamura | Sep 1997 | A |
5666946 | Langenback | Sep 1997 | A |
5670999 | Takeuchi et al. | Sep 1997 | A |
5685491 | Marks et al. | Nov 1997 | A |
5692644 | Gueret | Dec 1997 | A |
5707818 | Chudzik et al. | Jan 1998 | A |
5709202 | Lloyd et al. | Jan 1998 | A |
5714360 | Swan et al. | Feb 1998 | A |
5714551 | Bezwada et al. | Feb 1998 | A |
5718222 | Lloyd et al. | Feb 1998 | A |
D392184 | Weiler | Mar 1998 | S |
5724957 | Rubsamen et al. | Mar 1998 | A |
5744515 | Clapper | Apr 1998 | A |
5752502 | King | May 1998 | A |
5755218 | Johansson et al. | May 1998 | A |
5758637 | Ivri et al. | Jun 1998 | A |
5775506 | Grabenkort | Jul 1998 | A |
5788665 | Sekins | Aug 1998 | A |
5788819 | Onishi et al. | Aug 1998 | A |
5790151 | Mills | Aug 1998 | A |
5810004 | Ohki et al. | Sep 1998 | A |
5819730 | Stone et al. | Oct 1998 | A |
5823179 | Grychowski et al. | Oct 1998 | A |
5823428 | Humberstone et al. | Oct 1998 | A |
5829723 | Brunner et al. | Nov 1998 | A |
5836515 | Fonzes | Nov 1998 | A |
5839617 | Cater et al. | Nov 1998 | A |
5842468 | Denyer et al. | Dec 1998 | A |
5862802 | Bird | Jan 1999 | A |
5865171 | Cinquin | Feb 1999 | A |
5878900 | Hansen | Mar 1999 | A |
5893515 | Hahn et al. | Apr 1999 | A |
5894841 | Voges | Apr 1999 | A |
5897008 | Hansen | Apr 1999 | A |
5910698 | Yagi | Jun 1999 | A |
5915377 | Coffee | Jun 1999 | A |
5918637 | Fleischman | Jul 1999 | A |
5925019 | Ljungquist | Jul 1999 | A |
5938117 | Ivri | Aug 1999 | A |
5950619 | Van Der Linden et al. | Sep 1999 | A |
5954268 | Joshi et al. | Sep 1999 | A |
5960792 | Lloyd et al. | Oct 1999 | A |
5964417 | Amann et al. | Oct 1999 | A |
5970974 | Van Der Linden et al. | Oct 1999 | A |
5976344 | Abys et al. | Nov 1999 | A |
5993805 | Sutton et al. | Nov 1999 | A |
6000396 | Melker et al. | Dec 1999 | A |
6007518 | Kriesel et al. | Dec 1999 | A |
6012450 | Rubsamen | Jan 2000 | A |
6014970 | Ivri et al. | Jan 2000 | A |
6026809 | Abrams et al. | Feb 2000 | A |
6029666 | Aloy et al. | Feb 2000 | A |
6032665 | Psaros | Mar 2000 | A |
6037587 | Dowell et al. | Mar 2000 | A |
6045215 | Coulman | Apr 2000 | A |
6045874 | Himes | Apr 2000 | A |
6047818 | Warby et al. | Apr 2000 | A |
6055869 | Stemme et al. | May 2000 | A |
6060128 | Kim et al. | May 2000 | A |
6062212 | Davison et al. | May 2000 | A |
6068148 | Weiler | May 2000 | A |
6085740 | Ivri et al. | Jul 2000 | A |
6096011 | Trombley, III et al. | Aug 2000 | A |
6105877 | Coffee | Aug 2000 | A |
6106504 | Urrutia | Aug 2000 | A |
6116234 | Genova et al. | Sep 2000 | A |
6123413 | Agarwal et al. | Sep 2000 | A |
6139674 | Markham et al. | Oct 2000 | A |
6142146 | Abrams et al. | Nov 2000 | A |
6145963 | Pidwerbecki et al. | Nov 2000 | A |
6146915 | Pidwerbecki et al. | Nov 2000 | A |
6152130 | Abrams et al. | Nov 2000 | A |
6155676 | Etheridge et al. | Dec 2000 | A |
6158431 | Poole | Dec 2000 | A |
6161536 | Redmon et al. | Dec 2000 | A |
6163588 | Matsumoto et al. | Dec 2000 | A |
6182662 | McGhee | Feb 2001 | B1 |
6186141 | Pike et al. | Feb 2001 | B1 |
6196218 | Voges | Mar 2001 | B1 |
6196219 | Hess et al. | Mar 2001 | B1 |
6205999 | Ivri et al. | Mar 2001 | B1 |
6216916 | Maddox et al. | Apr 2001 | B1 |
6223746 | Jewett et al. | May 2001 | B1 |
6235177 | Borland et al. | May 2001 | B1 |
6254219 | Agarwal et al. | Jul 2001 | B1 |
6269810 | Brooker et al. | Aug 2001 | B1 |
6270473 | Schwebel | Aug 2001 | B1 |
6273342 | Terada et al. | Aug 2001 | B1 |
6318640 | Coffee | Nov 2001 | B1 |
6328030 | Kidwell et al. | Dec 2001 | B1 |
6328033 | Avrahami | Dec 2001 | B1 |
6341732 | Martin et al. | Jan 2002 | B1 |
6358058 | Strupat et al. | Mar 2002 | B1 |
6394363 | Arnott et al. | May 2002 | B1 |
6402046 | Loser | Jun 2002 | B1 |
6405934 | Hess et al. | Jun 2002 | B1 |
6427682 | Klimowicz et al. | Aug 2002 | B1 |
6443146 | Voges | Sep 2002 | B1 |
6443366 | Hirota et al. | Sep 2002 | B1 |
6467476 | Ivri et al. | Oct 2002 | B1 |
6530370 | Heinonen | Mar 2003 | B1 |
6540153 | Ivri | Apr 2003 | B1 |
6540154 | Ivri et al. | Apr 2003 | B1 |
6543443 | Klimowicz et al. | Apr 2003 | B1 |
6546927 | Litherland et al. | Apr 2003 | B2 |
6550472 | Litherland et al. | Apr 2003 | B2 |
6554201 | Klimowicz et al. | Apr 2003 | B2 |
6581595 | Murdock et al. | Jun 2003 | B1 |
6615824 | Power | Sep 2003 | B2 |
6629646 | Ivri | Oct 2003 | B1 |
6640804 | Ivri et al. | Nov 2003 | B2 |
6651650 | Yamamoto et al. | Nov 2003 | B1 |
6732944 | Litherland et al. | May 2004 | B2 |
6755189 | Ivri et al. | Jun 2004 | B2 |
6769626 | Haveri | Aug 2004 | B1 |
6782886 | Narayan et al. | Aug 2004 | B2 |
6814071 | Klimowicz et al. | Nov 2004 | B2 |
6845770 | Klimowicz et al. | Jan 2005 | B2 |
6851626 | Patel et al. | Feb 2005 | B2 |
6860268 | Bohn et al. | Mar 2005 | B2 |
6926208 | Ivri | Aug 2005 | B2 |
6978941 | Litherland et al. | Dec 2005 | B2 |
7066398 | Borland et al. | Jun 2006 | B2 |
20010013554 | Borland et al. | Aug 2001 | A1 |
20010015737 | Truninger et al. | Aug 2001 | A1 |
20020011247 | Ivri et al. | Jan 2002 | A1 |
20020078958 | Stenzler | Jun 2002 | A1 |
20020104530 | Ivri et al. | Aug 2002 | A1 |
20020121274 | Borland et al. | Sep 2002 | A1 |
20020134372 | Loeffler et al. | Sep 2002 | A1 |
20020134374 | Loeffler et al. | Sep 2002 | A1 |
20020134375 | Loeffler et al. | Sep 2002 | A1 |
20020134377 | Loeffler et al. | Sep 2002 | A1 |
20020162551 | Litherland | Nov 2002 | A1 |
20030140921 | Smith et al. | Jul 2003 | A1 |
20030150445 | Power et al. | Aug 2003 | A1 |
20030150466 | Patel et al. | Aug 2003 | A1 |
20030226906 | Ivri | Dec 2003 | A1 |
20040000598 | Ivri | Jan 2004 | A1 |
20040004133 | Ivri et al. | Jan 2004 | A1 |
20040011358 | Smaldone et al. | Jan 2004 | A1 |
20040035413 | Smaldone et al. | Feb 2004 | A1 |
20040035490 | Power | Feb 2004 | A1 |
20040050947 | Power et al. | Mar 2004 | A1 |
20040139968 | Loeffler et al. | Jul 2004 | A1 |
20040188534 | Litherland et al. | Sep 2004 | A1 |
20040256488 | Loeffler et al. | Dec 2004 | A1 |
20050011514 | Power et al. | Jan 2005 | A1 |
Number | Date | Country |
---|---|---|
477 855 | Oct 1969 | CH |
555 681 | Nov 1974 | CH |
0 049 636 | Apr 1982 | EP |
0 103 161 | Mar 1984 | EP |
0 134 847 | Mar 1985 | EP |
0 178 925 | Apr 1986 | EP |
0 387 222 | Sep 1990 | EP |
0 432 992 | Jun 1991 | EP |
0 476 991 | Mar 1992 | EP |
0 480 615 | Apr 1992 | EP |
0 510 648 | Oct 1992 | EP |
0 518 565 | Dec 1992 | EP |
0 542 723 | May 1993 | EP |
0 933 138 | Apr 1999 | EP |
0 923 957 | Jun 1999 | EP |
1 142 600 | Oct 2001 | EP |
973458 | Oct 1964 | GB |
1454597 | Nov 1976 | GB |
2 073 616 | Oct 1981 | GB |
2 101 500 | Jan 1983 | GB |
2 177 623 | Jan 1987 | GB |
2 240 494 | Aug 1991 | GB |
2 272 389 | May 1994 | GB |
57-23852 | Feb 1982 | JP |
57-105608 | Jul 1982 | JP |
58-61857 | Apr 1983 | JP |
58-139757 | Aug 1983 | JP |
59-142163 | Aug 1984 | JP |
60-4714 | Jan 1985 | JP |
61-8357 | Jan 1986 | JP |
61-215059 | Sep 1986 | JP |
2-135169 | May 1990 | JP |
2-189161 | Jul 1990 | JP |
06-007721 | Jan 1994 | JP |
WO 9207600 | May 1992 | WO |
WO 9211050 | Jul 1992 | WO |
WO 9217231 | Oct 1992 | WO |
WO 9301404 | Jan 1993 | WO |
WO 93010910 | Jun 1993 | WO |
WO 9409912 | May 1994 | WO |
WO 9609229 | Mar 1996 | WO |
WO 9631289 | Oct 1996 | WO |
WO 9707896 | Mar 1997 | WO |
WO 9917888 | Apr 1999 | WO |
WO 9963946 | Dec 1999 | WO |
WO 0037132 | Jun 2000 | WO |
Number | Date | Country | |
---|---|---|---|
20040139963 A1 | Jul 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10222178 | Aug 2002 | US |
Child | 10655642 | US | |
Parent | 09574168 | May 2000 | US |
Child | 10222178 | US | |
Parent | 09058344 | Apr 1998 | US |
Child | 09574168 | US | |
Parent | 08604313 | Feb 1996 | US |
Child | 09058344 | US | |
Parent | 08521641 | Aug 1995 | US |
Child | 08604313 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 08417311 | Apr 1995 | US |
Child | 10655642 | US |